Research and Development

Showing 15 posts of 9573 posts found.

Novartis image

Skin cancer pill shows ‘significant’ response

February 20, 2014 Research and Development, Sales and Marketing LDE225, Novartis, bolt, skin cancer, smo

Novartis is celebrating after its investigational pill targeting the most common form of skin cancer met its primary endpoint in …
claes_zackrisson_rsa

RSA appoints director of Information

February 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claes Zackrisson, rsa

Life sciences executive search and interim management firm RSA has appointed Claes Zackrisson as its first director of information. Zackrisson …
Servier image

Servier signs leukaemia deal

February 19, 2014 Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia

French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …
Biomarin image

Vimizin shown green light

February 19, 2014 Research and Development, Sales and Marketing BioMarin, FDA, congenital enzyme disorder, vimizin

Regulators have shown the green light to BioMarin Pharmaceutical’s Vimizim as a treatment for a rare enzyme deficiency which affects …
dina_tsiambaou_ema

EMA hires Accenture IT head

February 19, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dina Tsiambaou, EMA, IT

The European Medicines Agency (EMA) has welcomed Dina Tsiambaou as the new head of its Information Technology department. Tsiambaou joins …
gsk image

GSK starts rare blood trial

February 18, 2014 Research and Development, Sales and Marketing GSK, blood, mepolizumab

GlaxoSmithKline has begun a Phase III study to look at mepolizumab in a rare condition characterised by vasculitis – widespread …
liam_english_photo

EFPIA appoints comms head from Lilly

February 18, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, English, liam, lilly

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has hired its new comms director from Eli Lilly. Liam English …

Novartis pays out for US biotech

February 17, 2014 Research and Development, Sales and Marketing Cancer, Novartis, Vaccine, costim pharmaceuticals

Novartis is looking to shore up its cancer immunotherapy pipeline with the purchase of oncology specialist CoStim Pharmaceuticals. The Cambridge, …
Germany image

Germany focus: strength with control

February 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMNOG, EFPIA, Germany, IQWIG, NHS, NICE

Germany is the biggest pharmaceutical market in Europe and one of the biggest in the world, but new systems and …
graham_hetherington_shire

Shire chief financial officer steps down

February 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, hetherington

Shire’s chief financial officer (CFO) Graham Hetherington has notified the company of his decision to step down. Flemming Ornskov, Shire …
capture

Emperra appoints new chief executive

February 14, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing e-health, emperra, krey

Healthcare development firm Emperra E-Health Technologies has hired Dr Christian Krey as managing director and chief executive. Krey was previously …

Aesica hires director from Catalent

February 13, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aesica, Catalent, muir

Contract development and manufacturing organisation (CDMO) Aesica has appointed Ian Muir to the newly-created position of commercial managing director. Muir’s …
ICR image

ICR: ‘Pharma needs stronger incentives’

February 12, 2014 Research and Development, Sales and Marketing ICR, cancer research, itcc, pharma, r and d

The pharma industry must be given greater monetary help to persuade it to develop drugs which are specifically for children, …

Merck KGaA pushes biosimilars

February 12, 2014 Research and Development, Sales and Marketing Dr Reddy's, Merck KGaA, biosimilars, dr reddys, generics

Merck KGaA is to take big strides into the world of biosimilars, according to the German company’s chairman Karl-Ludwig Kley. …
The Gateway to Local Adoption Series

Latest content